Derivation of induced pluripotent stem cells (iPSCs) by retroviral transduction of skin fibroblasts from four patients suffering 7q11.23 microduplication syndrome

dc.contributor.authorKuebler, Bernd
dc.contributor.authorAran, Begoña
dc.contributor.authorFlores Peirats, Raquel
dc.contributor.authorPérez Jurado, Luis Alberto
dc.contributor.authorVeiga, Anna
dc.contributor.authorCuscó Martí, Ivon, 1973-
dc.contributor.authorCorominas, Roser
dc.date.accessioned2021-01-14T07:13:06Z
dc.date.available2021-01-14T07:13:06Z
dc.date.issued2020
dc.description.abstractSkin fibroblasts were obtained from four patients with 7q11.23 microduplication syndrome carrying the reciprocal rearrangement of Williams-Beuren syndrome at the 7q11.23 genomic region. Induced pluripotent stem cells (iPSCs) were generated by retroviral infection of fibroblasts with polycystronic vectors. The generated iPSC clones ESi058B, ESi057B, ESi070A and ESi071A had the 7q11.23 duplication with no additional genomic alterations, a stable karyotype, expressed pluripotency markers and could differentiate towards the three germ layers in vitro via embryoid body formation and in vivo by teratoma formation. Patient's derived iPSCs are a valuable resource for in vitro modeling of 7q11.23 microduplication syndrome. Resource Table.
dc.description.sponsorshipThis work was supported by the grants from Fundación Ramón Areces, the marathon “Todos Somos Raros, Todos Somos Únicos” P52, Spanish Ministerio de Ciencia, Innovación y Universidades “RTI2018-101960-A-I00”, CERCA Programme/Generalitat de Catalunya; Red de Terapia Celular, TerCel, founded by Retics, RD12/0019/0034; Plataforma de Recursos Biomoleculares y Bioinformaticos, PRB2, PT13/0001/0041; both founded by Instituto de Salud Carlos III-ISCIII/FEDER. RC was recipient of Marie Skłodowska-Curie Actions (656359, H2020) and Ramón y Cajal (RYC-2017-21636) fellowships.
dc.format.mimetypeapplication/pdf
dc.identifier.citationKuebler B, Aran B, Flores R, Pérez-Jurado LA, Veiga A, Cuscó I, Corominas R. Derivation of induced pluripotent stem cells (iPSCs) by retroviral transduction of skin fibroblasts from four patients suffering 7q11.23 microduplication syndrome. Stem Cell Res. 2020; 49:102092. DOI: 10.1016/j.scr.2020.102092
dc.identifier.doihttp://dx.doi.org/10.1016/j.scr.2020.102092
dc.identifier.issn1873-5061
dc.identifier.urihttp://hdl.handle.net/10230/46167
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofStem Cell Res. 2020; 49:102092
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/656359
dc.rights© 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleDerivation of induced pluripotent stem cells (iPSCs) by retroviral transduction of skin fibroblasts from four patients suffering 7q11.23 microduplication syndrome
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
Kuebler_scr_deri.pdf
Mida:
5.66 MB
Format:
Adobe Portable Document Format

Llicència

Drets